How many acquisitions has Thermo Fisher Scientific made so far?

Thermo Fisher Scientific has completed 54 acquisitions so far, with an average acquisition amount of $2.99B.

Which countries does Thermo Fisher Scientific usually acquire in?

Thermo Fisher Scientific has made acquisitions in 10 countries with the most activity in United States and United Kingdom.

Which sectors does Thermo Fisher Scientific target for acquisitions?

Most of Thermo Fisher Scientific's acquisitions are in Life Sciences Platforms and Tools (29) and Genomics (10).

In which year did Thermo Fisher Scientific make the most acquisitions?

Thermo Fisher Scientific was most active in 2021, with 5 acquisitions completed in that year.

List of 54 Acquisitions by Thermo Fisher Scientific (Apr 2026)

Q: Which is Thermo Fisher Scientific's latest acquisition?

Thermo Fisher Scientific's most recent acquisition is Clario, a CRO focused on providing clinical trial supply services for biopharma sector, acquired in November 2025 for $9B.

Most viewed in 2019

Thermo Fisher Scientific has made a total of 54 acquisitions. Peak acquisition years were 2021 and 2017, each with 5 acquisitions, followed by 2016 with 4. Its acquisition activity spans 10 countries, with significant focus in United States (36 acquisitions), United Kingdom (2), and France (2). The company has also acquired businesses across 24 sectors, notably in Life Sciences Platforms and Tools (29 acquisitions), Genomics (10), and Biopharma Outsourcing (5). Over the last five years (2020–2025), the average annual acquisition rate was 2.4, with 0 acquisitions completed in the current calendar year. The most recent acquisition involved Clario, a Philadelphia-based CRO founded in 1972 that provides clinical trial supply services for the biopharma sector, completed in November 2025 for $9B.

Here's the year on year acquisition history of Thermo Fisher Scientific:

Number of Total Acquisitions

Year	# Acquisitions
2025	1
2023	3
2022	3
2021	5
2020	2
2019	2
2018	2
2017	5
2016	4
2013	1
2012	4
2011	4
2010	4
2009	1
2008	3
2006	2
2005	3
2004	1
2003	2
1999	1

View all Acquisitions by Thermo Fisher Scientific

Recent acquisitions by Thermo Fisher Scientific

Thermo Fisher Scientific's most recent acquisition - Clario is a CRO focused on providing clinical trial supply services for biopharma sector, founded in 1972 and located in Philadelphia. Thermo Fisher Scientific acquired it in November 2025 for a price of $9B.

Here is the list of all acquisitions by Thermo Fisher Scientific sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Nov 05, 2025	Clario	$9B	WilmerHale, Latham & Watkins	64	476
Oct 17, 2023	Olink	$3.1B	Cravath, J P Morgan and 3 more	26	246
Jul 06, 2023	CorEvitas	$912M	William Blair, Ropes & Gray ... and 1 more	18	851
Jun 21, 2023	MarqMetrix	Undisclosed	-	79	642
Oct 31, 2022	The Binding Site	$2.61B	-	66	169